GLP-1 Market
LLY $1409.38 ▼ -0.1% NVO $40.19 ▼ -0.6% PFE $30.00 ▼ -2.2% VKTX $26.09 ▼ -2.8% KLRA $12.58 ▲ +3.5% GPCR $20.35 ▼ -0.6% RHHBY $59.18 ▼ -2.5%
Market data delayed up to 20 min · Source: Twelve Data
About this data Sourced primarily from ClinicalTrials.gov — a listing isn't proof of safety or FDA approval.

Pipeline and clinical trial information here comes primarily from ClinicalTrials.gov. A listing on ClinicalTrials.gov means a study has been registered — not that a treatment is proven safe, effective, or FDA-approved. Investigational treatments may never be approved. Who can join a trial is decided only by that trial's own study team.

Not yet reported

conventional iron

Company
Medeni Şermet
Mechanism
Mechanism not yet reported
Route
Oral
Recruiting trials
None currently listed

Efficacy results: Not yet reported

No recruiting studies currently listed

See all studies for this drug

Data source: ClinicalTrials.gov · trial data as of Nov 4, 2026

Trial details
  • Completed NCT NCT03112187

    FLIPS: Ferfer Liposomal Iron Performance Study

    Not yet reported PharmEvo Pvt Ltd 400 participants Est. completion 2019-01-31 1 site Stand-alone
    Other conditions: Iron Deficiency Anemia
    View official trial listing →
  • Completed NCT NCT04199234

    A Study to Compare the Tolerability of Microencapsulated Iron Compared to a Conventional Iron Supplement in the Market

    Not yet reported Universidad Católica San Antonio de Murcia 48 participants Est. completion 2021-03-08 1 site
    Other conditions: Supplement
    View official trial listing →
  • Completed NCT NCT07366502

    Liposomal vs Conventional Oral Iron After Sleeve Gastrectomy

    Not yet reported Medeni Şermet 70 participants Est. completion 2026-07-31 1 site
    Other conditions: İron Deficiency Anemia, Liposomal Iron Replacement, Conventional Iron Replacement
    View official trial listing →
Efficacy history

Not yet reported.

Safety

Not yet reported.

Sources

Also known as: conventional iron, conventional oral iron

Related On The Pen coverage

No related coverage yet.

This drug may be investigational and not yet approved for any use. Whether someone can join a clinical trial is determined only by that trial's own study team — On The Pen does not determine eligibility. Information here can change; always confirm current details on the official ClinicalTrials.gov listing or with the sponsor.